Induction of dog sperm capacitation by glycosaminoglycans and glycosaminoglycan amounts of oviductal and uterine fluids in bitches.
Ejaculated sperm collected from 12 beagle dogs were incubated in canine capacitation medium (CCM), supplemented with 5 microg/ml chondroitin sulfate A (CS), 5 microg/ml hyaluronic acid (HA), or 5 microg/ml heparin (HP) for 7 hr at 38 degrees C in a 5% CO2 in air atmosphere to investigate the effects of glycosaminoglycans (GAGs) on dog sperm capacitation. The percentages of motile sperm, hyperactivated sperm (%HY), and acrosome-reacted sperm (%AR) in all media were examined after 4 hr and 7 hr of incubation. The oviducts and uteri of 9 anestrous and 18 estrous beagle bitches were removed under halothane inhalation anesthesia to measure the total GAG amounts in oviductal and uterine fluids. The lumens of the ampulla of the oviducts, isthmus of the oviducts, and the uterine horns were each flushed with 1 ml HEPES-EDTA fluid. Total GAG amounts in the flush fluids obtained were measured with a spectrophotometer. Sperm motility (51-59%), %HY (79-86%), and %AR (31-36%) in CCM supplemented with CS, HA, or HP were significantly higher after 7 hr of incubation than when incubated in CCM without GAGs (P<0.01 or 0.05). The mean total GAG amounts in the fluids from the ampulla and isthmus of the oviducts and the uterine horns in the estrous bitches were higher than in the anestrous bitches. These results indicate that GAGs in the oviductal and uterine fluids in estrous bitches are associated with in vivo sperm capacitation.
Kawakami
E
E
Department of Reproduction, Nippon Veterinary and Animal Science University, Tokyo, Japan.
Arai
T
T
Oishi
I
I
Hori
T
T
Tsutsui
T
T
D020101:Acrosome Reaction / Q000502:physiology; D000423:Alcian Blue / Q000737:chemistry; D000818:Animals; D002809:Chondroitin Sulfates / Q000032:analysis / Q000494:pharmacology; D004396:Coloring Agents / Q000737:chemistry; D004285:Dogs / Q000502:physiology*; D004971:Estrus / Q000502:physiology; D005187:Fallopian Tubes / Q000737:chemistry / Q000502:physiology*; D005260:Female; D006025:Glycosaminoglycans / Q000032:analysis / Q000494:pharmacology*; D006493:Heparin / Q000032:analysis / Q000494:pharmacology; D006820:Hyaluronic Acid / Q000032:analysis / Q000494:pharmacology; D008297:Male; D013075:Sperm Capacitation / Q000187:drug effects / Q000502:physiology*; D013094:Spermatozoa / Q000502:physiology; D014599:Uterus / Q000737:chemistry / Q000502:physiology*
D004396:Coloring Agents; D006025:Glycosaminoglycans; D006820:Hyaluronic Acid; D006493:Heparin; D002809:Chondroitin Sulfates; D000423:Alcian Blue